Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

Accurate breast cancer risk prediction achieved with image conversion, AI-like classification

Computer scientists in the U.S. and China have demonstrated a mammographic image conversion method that incorporates optical-density features and combines with a computer-aided classification scheme to boost the accuracy of risk predictions for breast cancer.

Thumbnail

Dense breast tissue may await 20-something women who drink spirits rather than beer, wine

Young women who drink spirits—i.e., “hard liquor”—may be more prone to developing dense breast tissue than their peers who either stick to beer and wine or don’t drink at all.

MRI important in reducing re-excision rates in surgical management of HG DCIS

A study in the European Journal of Radiology suggests MRI could be an important tool in reducing the re-excision rates in the management of high grade (HG) ductal carcinoma in situ (DCIS), when used in preoperative diagnosis and evaluation.

Thumbnail

Managing Breast Imaging: Building Efficiency Across the Enterprise

Sponsored by Sectra

What tools and tactics are making breast imaging specialists and clinicians more efficient across the healthcare enterprise?

Thumbnail

Amyloid PET shows good additive value when standard PET isn’t conclusive on dementia

Patients with suspected dementia that remains unclarified after PET imaging with the standard radiotracer fluordeoxyglucose (FDG) should be sent for amyloid-busting PET with florbetaben (FBB), as the latter is highly useful in establishing a final diagnosis in such situations.

Hologic Introduces a More Comfortable Mammogram with the Launch of the SmartCurve Breast Stabilization System

MARLBOROUGH, Mass., Sept. 26, 2017—Hologic, Inc. (Nasdaq: HOLX) today announced the commercial availability of its new SmartCurve™ breast stabilization system, which has been clinically proven to deliver a more comfortable mammogram without compromising image quality, workflow or dose.

Mega trial looks to compare efficacy of 2D and 3D mammography

ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and the National Cancer Institute (NCI) are leading the Tomosynthesis Mammographic Imaging Screening Trial, the first randomized trial to compare 2D and 3D digital mammography screening.

Breast-care joint venture launches in Texas

Two large, Texas-based provider organizations have entered into a joint-venture agreement that, they say, will improve access to breast imaging and related services in and around Houston.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.